IPD 4.00% 4.8¢ impedimed limited

Ann: AstraZeneca Selects SOZO for Second Large Renal Trial, page-2

  1. 5,399 Posts.
    lightbulb Created with Sketch. 1239
    The company previously announced in September 2020 that AstraZeneca will use SOZO to track patient fluid volume in a clinical trial focused on heart failure and chronic kidney disease. A combined 375 SOZO devices will now be leased across 31 countries for the two trials. Together, the trials are expected to generate in excess of $4.5 million in revenue.

    gaining traction
 
watchlist Created with Sketch. Add IPD (ASX) to my watchlist
(20min delay)
Last
4.8¢
Change
-0.002(4.00%)
Mkt cap ! $97.10M
Open High Low Value Volume
5.0¢ 5.0¢ 4.8¢ $325.2K 6.664M

Buyers (Bids)

No. Vol. Price($)
1 29999 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.1¢ 206000 3
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
IPD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.